VEGF and CD31 association in pituitary adenomas

Pituitary tumors are usually less vascularized than the normal pituitary, and the role of angiogenesis in these adenomas is contentious. Appraisal of microvascular density and expression of the potent angiogenic vascular endothelial growth factor (VEGF) by immunohistochemistry has yielded controvers...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Cristina, C.
Otros Autores: Perez-Millan, M.I, Luque, G., Dulce, R.A, Sevlever, G., Berner, S.I, Becu-Villalobos, D.
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2010
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 17845caa a22015257a 4500
001 PAPER-22835
003 AR-BaUEN
005 20230518205426.0
008 190411s2010 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-77956472773 
024 7 |2 cas  |a vasculotropin, 127464-60-2; Antigens, CD31; Tumor Markers, Biological; Vascular Endothelial Growth Factor A 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a ENPAF 
100 1 |a Cristina, C. 
245 1 0 |a VEGF and CD31 association in pituitary adenomas 
260 |c 2010 
270 1 0 |m Becu-Villalobos, D.; Instituto de Biología y Medicina Experimental, Consejo Nacional de Investigaciones Científicas y Técnicas, Vuelta de Obligado 2490, Buenos Aires 1428, Argentina; email: dbecu@dna.uba.ar 
506 |2 openaire  |e Política editorial 
504 |a Folkman, J., Shing, Y., Angiogenesis (1992) J Biol Chem, 267, pp. 10931-4. , 1:CAS:528:DyaK38XksVSmu7s%3D 1375931 
504 |a Schechter, J., Ultrastructural changes in the capillary bed of human pituitary tumors (1972) Am J Pathol, 67, pp. 109-26. , 1:STN:280:DyaE383ms1ensw%3D%3D 5055626 
504 |a Jugenburg, M., Kovacs, K., Stefaneanu, L., Scheithauer, B.W., Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: A quantitative morphologic study (1995) Endocr Pathol, 6, pp. 115-24. , 10.1007/BF02739874 12114647 
504 |a Turner, H.E., Nagy, Z., Gatter, K.C., Esiri, M.M., Harris, A.L., Wass, J.A.H., Angiogenesis in pituitary adenomas and the normal pituitary gland (2000) Journal of Clinical Endocrinology and Metabolism, 85 (3), pp. 1159-1162. , DOI 10.1210/jc.85.3.1159 
504 |a Takada, K., Yamada, S., Teramoto, A., Correlation between tumor vascularity and clinical findings in patients with pituitary adenomas (2004) Endocrine Pathology, 15 (2), pp. 131-139. , DOI 10.1385/EP:15:2:131 
504 |a Pizarro, C.B., Oliveira, M.C., Pereira-Lima, J.F., Leaes, C.G., Kramer, C.K., Schuch, T., Barbosa-Coutinho, L.M., Ferreira, N.P., Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker (2009) Neuropathology, 29, pp. 40-4. , 10.1111/j.1440-1789.2008.00937.x 18673444 
504 |a Di Ieva, A., Grizzi, F., Gaetani, P., Goglia, U., Tschabitscher, M., Mortini, P., Baena, R., Euclidean and fractal geometry of microvascular networks in normal and neoplastic pituitary tissue (2008) Neurosurg Rev, 31, pp. 271-81. , 10.1007/s10143-008-0127-7 18327622 
504 |a Turner, H.E., Harris, A.L., Melmed, S., Wass, J.A.H., Angiogenesis in Endocrine Tumors (2003) Endocrine Reviews, 24 (5), pp. 600-632. , DOI 10.1210/er.2002-0008 
504 |a Vidal, S., Kovacs, K., Cohen, S.M., Stefaneanu, L., Lloyd, R.V., Scheithauer, B.W., Localization of vascular endothelial growth factor in non tumorous human pituitaries (1999) Endocr Pathol, 10, pp. 109-22. , 10.1007/BF02739823 
504 |a Mukdsi, J.H., Paul, A.L.D., Gutierrez, S., Roth, F.D., Aoki, A., Torres, A.I., Subcellular localisation of VEGF in different pituitary cells. Changes of its expression in oestrogen induced prolactinomas (2005) Journal of Molecular Histology, 36 (8-9), pp. 447-454. , DOI 10.1007/s10735-005-9012-7 
504 |a Lloyd, R.V., Scheithauer, B.W., Kuroki, T., Vidal, S., Kovacs, K., Stefaneanu, L., Vascular Endothelial Growth Factor (VEGF) Expression in Human Pituitary Adenomas and Carcinomas (1999) Endocr Pathol, 10, pp. 229-35. , 10.1007/BF02738884 1:CAS:528:DyaK1MXotVCit7w%3D 12114703 
504 |a Komorowski, J., Jankewicz, J., Stepien, H., Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours (2000) Cytobios, 101, pp. 151-9. , 1:CAS:528:DC%2BD3cXjtVGksLc%3D 10755214 
504 |a Gruszka, A., Kunert-Radek, J., Pawlikowski, M., Stepien, H., Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with pituitary adenomas (2005) Pituitary, 8, pp. 163-8. , 10.1007/s11102-005-5258-z 1:CAS:528:DC%2BD28XhvVSrt70%3D 16379029 
504 |a Lohrer, P., Gloddek, J., Hopfner, U., Losa, M., Uhl, E., Pagotto, U., Stalla, G.K., Renner, U., Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro (2001) Neuroendocrinology, 74 (2), pp. 95-105. , DOI 10.1159/000054675 
504 |a Nishikawa, R., Cheng, S.-Y., Nagashima, R., Su Huang, H.-J., Cavenee, W.K., Matsutani, M., Expression of vascular endothelial growth factor in human brain tumors (1998) Acta Neuropathologica, 96 (5), pp. 453-462. , DOI 10.1007/s004010050919 
504 |a McCabe, C.J., Boelaert, K., Tannahill, L.A., Heaney, A.P., Stratford, A.L., Khaira, J.S., Hussain, S., Gittoes, N.J., Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors (2002) J Clin Endocrinol Metab, 87, pp. 4238-44. , 10.1210/jc.2002-020309 1:CAS:528:DC%2BD38XntFOls7c%3D 12213878 
504 |a Mallea-Gil, M.S., Cristina, C., Perez-Millan, M.I., Ballarino, M.C., Rodriguez Villafañe, A.M., Stalldecker, G., Becu-Villalobos, D., Invasive giant prolactinoma with loss of therapeutic response to cabergoline: Expression of angiogenic markers (2009) Endocr Pathol, 20, pp. 35-50. , 10.1007/s12022-009-9057-3 1:CAS:528:DC%2BD1MXjsFyksrs%3D 19172414 
504 |a Cristina, C., Diaz-Torga, G., Baldi, A., Gongora, A., Rubinstein, M., Low, M.J., Becu-Villalobos, D., Increased pituitary vascular endothelial growth factor-A in dopaminergic D2 receptor knockout female mice (2005) Endocrinology, 146 (7), pp. 2952-2962. , http://endo.endojournals.org/cgi/reprint/146/7/2952, DOI 10.1210/en.2004-1445 
504 |a Iuchi, T., Saeki, N., Osato, K., Yamaura, A., Proliferation, vascular endothelial growth factor expression and cavernous sinus invasion in growth hormone secreting pituitary adenomas (2000) Acta Neurochirurgica, 142 (12), pp. 1345-1351. , DOI 10.1007/s007010070003 
504 |a Niveiro, M., Aranda, F.I., Peiro, G., Alenda, C., Pico, A., Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas (2005) Human Pathology, 36 (10), pp. 1090-1095. , DOI 10.1016/j.humpath.2005.07.015, PII S0046817705003965 
504 |a Viacava, P., Gasperi, M., Acerbi, G., Manetti, L., Cecconi, E., Bonadio, A.G., Naccarato, A.G., Martino, E., Microvascular density and vascular endothelial growth factor expression in normal pituitary tissue and pituitary adenomas (2003) J Endocrinol Investig, 26, pp. 23-8. , 1:CAS:528:DC%2BD3sXjtVKmtrg%3D 
504 |a Turner, H.E., Nagy, Z., Gatter, K.C., Esiri, M.M., Harris, A.L., Wass, J.A., Angiogenesis in pituitary adenomas - Relationship to endocrine function, treatment and outcome (2000) J Endocrinol, 165, pp. 475-81. , 10.1677/joe.0.1650475 1:CAS:528:DC%2BD3cXjvFegtLs%3D 10810311 
504 |a Rivard, A., Fabre, J.E., Silver, M., Chen, D., Murohara, T., Kearney, M., Magner, M., Isner, J.M., Age-dependent impairment of angiogenesis (1999) Circulation, 99, pp. 111-20. , 1:CAS:528:DyaK1MXnsFCrsg%3D%3D 9884387 
504 |a Itoh, J., Serizawa, A., Kawai, K., Ishii, Y., Teramoto, A., Osamura, R.Y., Vascular networks and endothelial cells in the rat experimental pituitary glands and in the human pituitary adenomas (2003) Microscopy Research and Technique, 60 (2), pp. 231-235. , DOI 10.1002/jemt.10261 
504 |a Pawlikowski, M., Pisarek, H., Jaranowska, M., Immunocytochemical investigations on the vascularization of pituitary adenomas (1997) Endocr Pathol, 8, pp. 189-93. , 10.1007/BF02738785 12114722 
504 |a Vidal, S., Kovacs, K., Horvath, E., Scheithauer, B.W., Kuroki, T., Lloyd, R.V., Microvessel density in pituitary adenomas and carcinomas (2001) Virchows Archiv, 438 (6), pp. 595-602. , DOI 10.1007/s004280000373 
504 |a Thapar, K., Kovacs, K., Scheithauer, B.W., Stefaneanu, L., Horvath, E., Pernicone, P.J., Murray, D., Laws Jr., E.R., Proliferative activity and invasiveness among pituitary adenomas and carcinomas: An analysis using the MIB-1 antibody (1996) Neurosurgery, 38 (1), pp. 99-107. , DOI 10.1097/00006123-199601000-00024 
504 |a Hsu, D.W., Hakim, F., Biller, B.M., De La, M.S., Zervas, N.T., Klibanski, A., Hedley-Whyte, E.T., Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence (1993) J Neurosurg, 78, pp. 753-61. , 10.3171/jns.1993.78.5.0753 1:STN:280:DyaK3s3isV2ksQ%3D%3D 8096873 
504 |a Vidal, S., Horvath, E., Kovacs, K., Lloyd, R.V., Scheithauer, B.W., Microvascular structural entropy: A novel approach to assess angiogenesis in pituitary tumors (2003) Endocr Pathol, 14, pp. 239-47. , 10.1007/s12022-003-0016-0 14586069 
504 |a Turner, H.E., Nagy, Z., Gatter, K.C., Esiri, M.M., Wass, J.A., Harris, A.L., Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: Relationship to tumour behaviour (2000) Br J Cancer, 82, pp. 1441-5. , 1:CAS:528:DC%2BD3cXivFGisbw%3D 10780524 
504 |a Nor, J.E., Christensen, J., Mooney, D.J., Polverini, P.J., Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression (1999) Am J Pathol, 154, pp. 375-84. , 1:CAS:528:DyaK1MXjtVCqsbk%3D 10027396 
504 |a Arita, K., Kurisu, K., Tominaga, A., Sugiyama, K., Eguchi, K., Hama, S., Yoshioka, H., Kanou, Y., Relationship between intratumoral hemorrhage and overexpression of vascular endothelial growth factor (VEGF) in pituitary adenoma (2004) Hiroshima J Med Sci, 53, pp. 23-7. , 1:CAS:528:DC%2BD2cXotVGqu7c%3D 15453394 
504 |a Folberg, R., Hendrix, M.J., Maniotis, A.J., Vasculogenic mimicry and tumor angiogenesis (2000) Am J Pathol, 156, pp. 361-81. , 1:STN:280:DC%2BD3c7jt1yjtw%3D%3D 10666364 
504 |a Joseph, F., Younis, N., Haydon, G., Adams, D.H., Wynne, S., Gillet, M.B., Maurice, Y.M., Jones, I.R., Peliosis of the spleen with massive recurrent haemorrhagic ascites, despite splenectomy, and associated with elevated levels of vascular endothelial growth factor (2004) European Journal of Gastroenterology and Hepatology, 16 (12), pp. 1401-1406. , DOI 10.1097/00042737-200412000-00027 
504 |a Park, Y.N., Kim, Y.B., Yang, K.M., Park, C., Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis (2000) Arch Pathol Lab Med, 124, pp. 1061-5. , 1:CAS:528:DC%2BD3cXlsFWjurc%3D 10888784 
504 |a Wong, A.K., Alfert, M., Castrillon, D.H., Shen, Q., Holash, J., Yancopoulos, G.D., Chin, L., Excessive tumor-elaborated VEGF and its neutralization define a lethal paraneoplastic syndrome (2001) Proceedings of the National Academy of Sciences of the United States of America, 98 (13), pp. 7481-7486. , DOI 10.1073/pnas.121192298 
504 |a Mohammed, S., Syro, L.V., Scheithauer, B.W., Abad, A., Uribe, H., Rotondo, F., Horvath, E., Kovacs, K., Pituitary adenoma with peliosis: A report of two cases (2009) Endocr Pathol, 20, pp. 41-5. , 10.1007/s12022-008-9056-9 19089655 
504 |a Coire, C.I., Horvath, E., Kovacs, K., Smyth, H.S., Ezzat, S., Cushing's syndrome from an ectopic pituitary adenoma with peliosis: A histological, immunohistochemical, and ultrastructural study and review of the literature (1997) Endocr Pathol, 8, pp. 65-74. , 10.1007/BF02739709 12114673 
504 |a Cristina, C., Garcia-Tornadu, I., Diaz-Torga, G., Rubinstein, M., Low, M.J., Becu-Villalobos, D., Dopaminergic D2 receptor knockout mouse: An animal model of prolactinoma (2006) Frontiers of Hormone Research, 35, pp. 50-63. , DOI 10.1159/000094308, Pituitary Today: Molecular, Physiological and Clinical Aspects 
504 |a Kuchenbauer, F., Theodoropoulou, M., Hopfner, U., Stalla, J., Renner, U., Tonn, J.C., Low, M.J., Paez-Pereda, M., Laminin inhibits lactotroph proliferation and is reduced in early prolactinoma development (2003) Molecular and Cellular Endocrinology, 207 (1-2), pp. 13-20. , DOI 10.1016/S0303-7207(03)00237-5 
504 |a Lloyd, R.V., Vidal, S., Horvath, E., Kovacs, K., Scheithauer, B., Angiogenesis in normal and neoplastic pituitary tissues (2003) Microscopy Research and Technique, 60 (2), pp. 244-250. , DOI 10.1002/jemt.10263 
520 3 |a Pituitary tumors are usually less vascularized than the normal pituitary, and the role of angiogenesis in these adenomas is contentious. Appraisal of microvascular density and expression of the potent angiogenic vascular endothelial growth factor (VEGF) by immunohistochemistry has yielded controversial results, as a broad spectrum of immunostaining can be found. We determined the protein expression of VEGF and CD31, an endothelial marker, in a series of 56 surgically removed pituitary adenomas using Western blot assay. Prolactinomas had higher VEGF protein expression compared to nonfunctioning or ACTH- and GH-secreting adenomas, while CD31 was similar in the different adenoma histotypes. VEGF and CD31 were not affected by sex, age, years of adenoma evolution, or proliferation rate (Ki67 and PCNA) for all adenoma types. Only in nonfunctioning adenomas CD31 concentration increased significantly with age. There was a positive correlation between CD31 and VEGF expression when all adenoma histotypes were considered, or when prolactinomas and nonfunctioning adenomas were evaluated separately. The positive association of VEGF and CD31 expression suggests the participation of angiogenesis in adenoma development, while epithelial cell proliferation in pituitary tumors is not directly related to VEGF or CD31 expression, and other factors, such as primary genetic alterations may be involved. © 2010 Springer Science+Business Media, LLC.  |l eng 
536 |a Detalles de la financiación: Consejo Nacional de Investigaciones Científicas y Técnicas 
536 |a Detalles de la financiación: Fundación Florencio Fiorini 
536 |a Detalles de la financiación: Agencia Nacional de Promoción Científica y Tecnológica, N206, PICT 2006 
536 |a Detalles de la financiación: Fundación Alberto J. Roemmers 
536 |a Detalles de la financiación: De Blindas Vänner 
536 |a Detalles de la financiación: Consejo Nacional de Investigaciones Científicas y Técnicas, PIP 640 
536 |a Detalles de la financiación: CC and MIPM shared the work equally. C.Cristina.M.I.Perez-Millan.G.Luque.R.A.Dulce. D. Becu-Villalobos (*) Instituto de Biología y Medicina Experimental, Consejo Nacional de Investigaciones Científicas y Técnicas, Vuelta de Obligado 2490, 1428 Buenos Aires, Argentina e-mail: dbecu@dna.uba.ar 
536 |a Detalles de la financiación: Acknowledgments This work was supported by grants from CONICET (PIP 640 to DBV), Fundación Alberto J. Roemmers (DBV), Fundación Fiorini (DBV), and Agencia Nacional de Promoción Científica y Técnica, Buenos Aires, Argentina (PICT 2006, N206, to DBV). 
593 |a Instituto de Biología y Medicina Experimental, Consejo Nacional de Investigaciones Científicas y Técnicas, Vuelta de Obligado 2490, Buenos Aires 1428, Argentina 
593 |a Universidad Nacional Del Noroeste de la Provincia de Buenos Aires (UNNOBA), Roque Sáenz Peña 456, 6000 Buenos Aires Junín, Argentina 
593 |a Department of Neuropathology, Institute for Neurological Research FLENI, Montañeses 2325, Buenos Aires C1428AQK Buenos Aires, Argentina 
593 |a Department of Neurosurgery, Hospital Santa Lucía, Buenos Aires 1232, Argentina 
690 1 0 |a ANGIOGENESIS 
690 1 0 |a CD31 
690 1 0 |a PELIOISIS 
690 1 0 |a PITUITARY ADENOMA 
690 1 0 |a PROLIFERATION 
690 1 0 |a VEGF 
690 1 0 |a CD31 ANTIGEN 
690 1 0 |a CYCLINE 
690 1 0 |a KI 67 ANTIGEN 
690 1 0 |a VASCULOTROPIN 
690 1 0 |a ADULT 
690 1 0 |a AGE 
690 1 0 |a ANGIOGENESIS 
690 1 0 |a ARTICLE 
690 1 0 |a CARCINOGENESIS 
690 1 0 |a CELL PROLIFERATION 
690 1 0 |a CORRELATION ANALYSIS 
690 1 0 |a DISEASE COURSE 
690 1 0 |a EPITHELIUM CELL 
690 1 0 |a FEMALE 
690 1 0 |a GENDER 
690 1 0 |a GROWTH HORMONE SECRETING ADENOMA 
690 1 0 |a HISTOPATHOLOGY 
690 1 0 |a HUMAN 
690 1 0 |a HUMAN TISSUE 
690 1 0 |a HYPOPHYSIS ADENOMA 
690 1 0 |a MAJOR CLINICAL STUDY 
690 1 0 |a MALE 
690 1 0 |a MUTATION 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a PROLACTINOMA 
690 1 0 |a PROTEIN EXPRESSION 
690 1 0 |a TUMOR GROWTH 
690 1 0 |a WESTERN BLOTTING 
690 1 0 |a ADENOMA 
690 1 0 |a ADULT 
690 1 0 |a ANTIGENS, CD31 
690 1 0 |a BLOTTING, WESTERN 
690 1 0 |a FEMALE 
690 1 0 |a HUMANS 
690 1 0 |a MALE 
690 1 0 |a PITUITARY NEOPLASMS 
690 1 0 |a TUMOR MARKERS, BIOLOGICAL 
690 1 0 |a VASCULAR ENDOTHELIAL GROWTH FACTOR A 
700 1 |a Perez-Millan, M.I. 
700 1 |a Luque, G. 
700 1 |a Dulce, R.A. 
700 1 |a Sevlever, G. 
700 1 |a Berner, S.I. 
700 1 |a Becu-Villalobos, D. 
773 0 |d 2010  |g v. 21  |h pp. 154-160  |k n. 3  |p Endocr. Pathol.  |x 10463976  |t Endocrine Pathology 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956472773&doi=10.1007%2fs12022-010-9119-6&partnerID=40&md5=635d1e9e689baea6dbf1ac65b1fc1629  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1007/s12022-010-9119-6  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_10463976_v21_n3_p154_Cristina  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_10463976_v21_n3_p154_Cristina  |y Registro en la Biblioteca Digital 
961 |a paper_10463976_v21_n3_p154_Cristina  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 83788